Cette liste est basée sur les listes de surveillance des personnes sur Stock Events qui suivent GERM. Il ne s'agit pas d'une recommandation d'investissement.
The index tracks the performance of U.S.-listed equity securities or depositary receipts of companies that (i) perform research, development, and commercialization of treatments or vaccines for infectious diseases or (ii) engage in the research, development, manufacturing, and provision of biological tests for patients. The fund invests at least 80% of its total assets in the component securities of the index. The fund is non-diversified.